# Optimal Timing of Dinoprostone Administration Prior to Office Hysteroscopy

> **NCT04085757** · PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 180 (actual)

## Conditions studied

- Dinoprostone Timing

## Interventions

- **DRUG:** long interval dinoprostone
- **DRUG:** short interval dinoprostone

## Key facts

- **NCT ID:** NCT04085757
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-15
- **Primary completion:** 2019-12-15
- **Final completion:** 2020-01-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2021-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04085757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04085757, "Optimal Timing of Dinoprostone Administration Prior to Office Hysteroscopy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04085757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*